KRAS and cancer: Since activation of Pi3k is required for Kras induction and maintenance of PDAC in mice but is inhibited by Sstr2, these findings offer a mechanistic explanation of why expression of oncogenic Kras in the presence of ongoing Sstr2 expression is sufficient to initiate carcinogenesis but not progression to cancer.